190 related articles for article (PubMed ID: 2266373)
1. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
McLeod JG; Hammond SR; Hallpike JF
Med J Aust; 1994 Feb; 160(3):117-22. PubMed ID: 8295576
[TBL] [Abstract][Full Text] [Related]
3. HLA determinants in familial multiple sclerosis.
Grasso MG; Cutrupi F; Bernardi S; Trabace S; Pozzilli C; Cappellacci S; Fieschi C
Neuroepidemiology; 1992; 11(2):85-9. PubMed ID: 1495578
[TBL] [Abstract][Full Text] [Related]
4. HLA antigens in multiple sclerosis of northern Spanish population.
López-Larrea C; Uría DF; Coto E
J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
[TBL] [Abstract][Full Text] [Related]
5. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.
Simpson S; Blizzard L; Otahal P; Van der Mei I; Taylor B
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1132-41. PubMed ID: 21478203
[TBL] [Abstract][Full Text] [Related]
6. Possible significance of familial aggregations of multiple sclerosis.
Mumford C
Br J Hosp Med; 1991 Jul; 46(1):55-7. PubMed ID: 1868308
[TBL] [Abstract][Full Text] [Related]
7. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis in New Zealand.
Alla S; Mason DF
J Clin Neurosci; 2014 Aug; 21(8):1288-91. PubMed ID: 24503208
[TBL] [Abstract][Full Text] [Related]
9. A reassessment of the distribution of multiple sclerosis. Part one.
Kurtzke JF
Acta Neurol Scand; 1975 Feb; 51(2):110-36. PubMed ID: 46682
[TBL] [Abstract][Full Text] [Related]
10. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
González-Enríquez GV; Torres-Mendoza BM; Márquez-Pedroza J; Macías-Islas MA; Ortiz GG; Cruz-Ramos JA
Immunogenetics; 2018 Aug; 70(8):547-551. PubMed ID: 29397401
[TBL] [Abstract][Full Text] [Related]
11. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
12. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
13. The increased susceptibility of women to multiple sclerosis.
Duquette P; Pleines J; Girard M; Charest L; Senecal-Quevillon M; Masse C
Can J Neurol Sci; 1992 Nov; 19(4):466-71. PubMed ID: 1423044
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis.
Sandberg-Wollheim M; Ciusani E; Salmaggi A; Pociot F
Mult Scler; 1995 Nov; 1(3):181-5. PubMed ID: 9345451
[TBL] [Abstract][Full Text] [Related]
15. A reassessment of the distribution of multiple sclerosis.
Kurtzke JF
Acta Neurol Scand; 1975 Feb; 51(2):137-57. PubMed ID: 1114878
[TBL] [Abstract][Full Text] [Related]
16. MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Taylor BV; Pearson JF; Clarke G; Mason DF; Abernethy DA; Willoughby E; Sabel C
Mult Scler; 2010 Dec; 16(12):1422-31. PubMed ID: 20813774
[TBL] [Abstract][Full Text] [Related]
17. C4AQ0 and HLA-DR2, risk factors in multiple sclerosis.
Marcelli-Barge A; Poirier JC; Chantome R; Lepage V; Khalil I; Colombani J
Res Immunol; 1990 Oct; 141(8):739-41. PubMed ID: 2089531
[No Abstract] [Full Text] [Related]
18. Genetic and environmental factors and the distribution of multiple sclerosis in Europe.
Handel AE; Handunnetthi L; Giovannoni G; Ebers GC; Ramagopalan SV
Eur J Neurol; 2010 Sep; 17(9):1210-1214. PubMed ID: 20345929
[TBL] [Abstract][Full Text] [Related]
19. Association of the HLA region with multiple sclerosis as confirmed by a genome screen using >10,000 SNPs on DNA chips.
Gödde R; Rohde K; Becker C; Toliat MR; Entz P; Suk A; Müller N; Sindern E; Haupts M; Schimrigk S; Nürnberg P; Epplen JT
J Mol Med (Berl); 2005 Jun; 83(6):486-94. PubMed ID: 15770496
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and genetics of multiple sclerosis.
Compston A; Sadovnick AD
Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):175-81. PubMed ID: 1623245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
